Abstract:Polyamines are critical cellular components that regulate a variety of processes, including translation, cell cycling, and nucleic acid metabolism. The polyamines, putrescine, spermidine, and spermine, are found abundantly within cells and are positively-charged at physiological pH. Polyamine metabolism is connected to distinct other metabolic pathways, including nucleotide and amino acid metabolism. However, the breadth of the effect of polyamines on cellular metabolism remains to be fully understood. We recently demonstrated a role for polyamines in cholesterol metabolism, and following these studies, we measured the impact of polyamines on global lipid metabolism. We find that lipid droplets increase in number and size with polyamine depletion. We further demonstrate that lipid anabolism is markedly decreased, and lipid accumulation is due to reduced mitochondrial fatty acid oxidation. In fact, mitochondrial structure and function are largely ablated with polyamine depletion. To compensate, cells depleted of polyamines switch from aerobic respiration to glycolysis in a polyamine depletion-mediated Warburg-like effect. Finally, we show that inhibitors of lipid metabolism are broadly antiviral, suggesting that polyamines and lipids are promising antiviral targets. Together, these data demonstrate a novel role for polyamines in mitochondrial function, lipid metabolism, and cellular energetics. Cells and viruses rely on metabolic circuits to survive and replicate. The small metabolites called polyamines support cellular homeostasis by supporting mitochondrial function. Without polyamines, lipids accumulate in cells because they are not catabolized by fatty acid oxidation. Cells depleted of polyamines switch from aerobic respiration to glycolysis for energy production, similar to cancer cells in hypoxic environments. We also show that varied viruses use lipids to replicate, and targeting lipids with small molecule inhibitors can reduce virus replication. Overall, our work makes a new connection between polyamines and lipid metabolism and highlights potential pathways to target for antiviral therapies.

Targeting Polyamine Metabolism for Control of Human Viral Diseases

Virion-Associated Polyamines Transmit with Bunyaviruses to Maintain Infectivity and Promote Entry

Host Cell Targets for Unconventional Antivirals against RNA Viruses

Functionalized Nanoparticles in Prevention and Targeted Therapy of Viral Diseases With Neurotropism Properties, Special Insight on COVID-19

Targeting Selective Autophagy as a Therapeutic Strategy for Viral Infectious Diseases

Antivirals against human polyomaviruses: Leaving no stone unturned

Polyamines mediate cellular energetics and lipid metabolism through mitochondrial respiration to facilitate virus replication

Antivirals with common targets against highly pathogenic viruses

New perspective of small-molecule antiviral drugs development for RNA viruses

The Efficacy of Viral Capsid Inhibitors in Human Enterovirus Infection and Associated Diseases.

Virus Infection Participates in the Occurrence and Development of Human Diseases Through Monoamine Oxidase

Polyamines and eIF5A hypusination facilitate SREBP2 synthesis and cholesterol production leading to enhanced enterovirus attachment and infection

Research Progress on the Replication Mechanisms of Important Human-Infecting RNA Viruses and Polymerase-Directed Drug Development

Recent Advances in the Molecular Design and Applications of Viral RNA-targeting Antiviral Modalities

Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses

Polymeric Prodrugs Targeting Polyamine Metabolism Inhibit Zika Virus Replication.

Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses

Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections

Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19

Integrated human-virus metabolic stoichiometric modelling predicts host-based antiviral targets against Chikungunya, Dengue and Zika viruses

Is heparan sulfate a target for inhibition of RNA virus infection?